Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?

L Alou; M J Giménez; D Sevillano; L Aguilar; N González; O Echeverría; M Torrico; P Coronel; J Prieto

doi:10.1093/jac/dkm015

Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?

Identifier:nobleid.org/w1/20260515/CE7FD73F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CE7FD73F.svg?ark=w1%2F20260515%2FCE7FD73F)](https://nobleid.org/work/w1/20260515/CE7FD73F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?

Identifier:nobleid.org/w1/20260515/CE7FD73F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CE7FD73F.svg?ark=w1%2F20260515%2FCE7FD73F)](https://nobleid.org/work/w1/20260515/CE7FD73F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work